1 / 7

To Witness Lucrative Growth Through 2027

North America Clinical Trials Market To Hit USD 29.6 Bn By 2027. North America clinical trials market outlook is earmarked with optimistic patterns, thanks to the unprecedented need for more effective medications and treatments. In the light of the coronavirus pandemic, the demand for effective infectious disease treatments, personalized medicine, and orphan drugs has shot up significantly across Canada and the U.S. Considering these developments, the R&D expenditure is expanding.

sudeepkedar77
Download Presentation

To Witness Lucrative Growth Through 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America Clinical Trials Market Revenue To Show Tremendous Growth Till 2027 ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. North America Clinical Trials Market To Hit USD 29.6 Bn By 2027. North America clinical trials market outlook is earmarked with optimistic patterns, thanks to the unprecedented need for more effective medications and treatments. In the light of the coronavirus pandemic, the demand for effective infectious disease treatments, personalized medicine, and orphan drugs has shot up significantly across Canada and the U.S. Considering these developments, the R&D expenditure is expanding. • The following major drivers are likely to push the revenue over 2021-2027 in North America: • Rising number of regulatory approvals for clinical trials • Benefits of outsourcing to contract research organizations or CROs • Availability of patients and volunteers • Access to a vast information database and latest tools • Adoption of clinical trial management systems (CTMS) ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Get sample copy of this research report @ • https://www.graphicalresearch.com/request/2002/sample • Request for customization @ • https://www.graphicalresearch.com/request/2002/customize-this-report ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. The exponential ascent can be attributed to the ongoing research activities, supported by the availability of advanced tools, skilled professionals, and substantial investments toward them. By phases, the industry share is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials market share has been exhibiting a rising curve over the last few months in North America. The trend is expected to remain aloft through the next few years, owing to the rising emphasis on studying the comparative effects of new treatments with existing ones. On account of their higher complexity and necessity for a larger patient pool, these clinical trials require more frequent outsourcing than phase I or II trials. Based on therapeutic categories, North America clinical trials industry size is divided into oncology, cardiology, autoimmune disease, ophthalmology, dermatology, infectious diseases, among others. The cardiology clinical trials industry share in North America is slated to cross $2.6 billion by 2027. Investments in R&D are growing due to the need for cost-effective medications for heart conditions. As the percentage of cardiac patients is on the rise, the number of pipeline drugs in cardiology has gone up to 190. These drugs are being evaluated for efficacy and safety, targeting lipid disorders, heart failure, stroke, and vascular diseases. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Segments of North American Clinical Trial Market; • North America Market, By Study Design • Interventional study • Observation study • Expanded access study • North America Market, By Therapeutic Area • Autoimmune disease • Oncology • Cardiology • Infectious disease • Dermatology • Ophthalmology • Others ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  6. About Graphical Research: Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle. Contact Us: Parikhit B. Corporate sales, Graphical Research Email:sales@graphicalresearch.comWeb: https://www.graphicalresearch.com ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  7. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related